v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Total Apollo Global Management, Inc. Stockholders’ Equity
Common Stock
Series A Mandatory Convertible Preferred Stock
Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2024     565,738,933          
Beginning balance at Dec. 31, 2024 $ 30,964 $ 17,253   $ 1,398 $ 15,327 $ 6,022 $ (5,494) $ 13,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 1,780 1,072   49   1,023   708
Other comprehensive income (loss) 2,212 1,801         1,801 411
Capital increase related to equity-based compensation 273 273     273      
Capital contributions 1,215             1,215
Dividends/distributions (1,682) (633)   (49)   (584)   (1,049)
Payments related to issuances of common stock for equity-based awards (in shares)     4,505,089          
Payments related to issuances of common stock for equity-based awards (524) (524)     18 (542)    
Repurchase of common stock (in shares)     (1,392,000)          
Repurchase of common stock (193) (193)     (193)      
Stock option exercises (in shares)     1,418,836          
Stock option and warrant exercises 13 13     13      
Consolidation/deconsolidation of VIEs (442)             (442)
Issuance of warrants 54 54     54      
Issuance of common stock related to equity transactions (in shares)     540,177          
Accretion of redeemable non-controlling interests 5 5     5      
Issuance of common stock to donor-advised fund (in shares)     1,213,003          
Issuance of common stock to donor-advised fund 200 200     200      
Other changes in equity of non-controlling interests (14)             (14)
Ending balance (in shares) at Jun. 30, 2025     572,024,038          
Ending balance at Jun. 30, 2025 33,861 19,321   1,398 15,697 5,919 (3,693) 14,540
Beginning balance (in shares) at Mar. 31, 2025     570,432,275          
Beginning balance at Mar. 31, 2025 32,344 17,976   1,398 15,527 5,634 (4,583) 14,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 842 630   25   605   212
Other comprehensive income (loss) 1,113 890         890 223
Capital increase related to equity-based compensation 145 145     145      
Capital contributions 579             579
Dividends/distributions (1,164) (331)   (25)   (306)   (833)
Payments related to issuances of common stock for equity-based awards (in shares)     172,927          
Payments related to issuances of common stock for equity-based awards (2) (2)     12 (14)    
Stock option exercises (in shares)     1,418,836          
Stock option and warrant exercises 13 13     13      
Other changes in equity of non-controlling interests (9)             (9)
Ending balance (in shares) at Jun. 30, 2025     572,024,038          
Ending balance at Jun. 30, 2025 $ 33,861 19,321   1,398 15,697 5,919 (3,693) 14,540
Beginning balance (in shares) at Dec. 31, 2025 578,981,398   578,981,398          
Beginning balance at Dec. 31, 2025 $ 42,515 23,341   1,398 16,954 7,634 (2,645) 19,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 678 (545)   49   (594)   1,223
Other comprehensive income (loss) (880) (564)         (564) (316)
Capital increase related to equity-based compensation 411 411     411      
Capital contributions 2,085             2,085
Dividends/distributions (2,126) (703)   (49)   (654)   (1,423)
Payments related to issuances of common stock for equity-based awards (in shares)     2,632,585          
Payments related to issuances of common stock for equity-based awards (216) (216)     24 (240)    
Repurchase of common stock (in shares)     (5,926,713)          
Repurchase of common stock (733) (733)     (733)      
Stock option exercises (in shares)     284,482          
Stock option and warrant exercises 10 10     10      
Consolidation/deconsolidation of VIEs (288)             (288)
Other changes in equity of non-controlling interests $ 26 5     2 3   21
Ending balance (in shares) at Jun. 30, 2026 575,971,752   575,971,752          
Ending balance at Jun. 30, 2026 $ 41,482 21,006   1,398 16,668 6,149 (3,209) 20,476
Beginning balance (in shares) at Mar. 31, 2026     576,507,457          
Beginning balance at Mar. 31, 2026 39,533 19,951   1,398 16,540 5,157 (3,144) 19,582
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 2,089 1,361   25   1,336   728
Other comprehensive income (loss) (207) (65)         (65) (142)
Capital increase related to equity-based compensation 216 216     216      
Capital contributions 1,138             1,138
Dividends/distributions (922) (367)   (25)   (342)   (555)
Payments related to issuances of common stock for equity-based awards (in shares)     173,189          
Payments related to issuances of common stock for equity-based awards 4 4     9 (5)    
Repurchase of common stock (in shares)     (743,882)          
Repurchase of common stock (99) (99)     (99)      
Stock option exercises (in shares)     34,988          
Stock option and warrant exercises 2 2     2      
Consolidation/deconsolidation of VIEs (288)             (288)
Other changes in equity of non-controlling interests $ 16 3       3   13
Ending balance (in shares) at Jun. 30, 2026 575,971,752   575,971,752          
Ending balance at Jun. 30, 2026 $ 41,482 $ 21,006   $ 1,398 $ 16,668 $ 6,149 $ (3,209) $ 20,476